An in vivo genome wide gene expression study of circulating monocytes suggested GBP1, STAT1 and CXCL10 as novel risk genes for the differentiation of peak bone mass
An in vivo genome wide gene expression study of circulating monocytes suggested GBP1, STAT1 and CXCL10 as novel risk genes for the differentiation of peak bone mass
复制标题
循环单核细胞的体内全基因组基因表达研究表明 GBP1、STAT1 和 CXCL10 是峰值骨量分化的新风险基因
DOI:
10.1016/j.bone.2008.05.016
复制
发表时间:
2009-05-01
期刊:
影响因子:
4.1
通讯作者:
Deng, Hong-Wen
中科院分区:
文献类型:
--
作者:
Lei, Shu-Feng;Wu, Shan;Deng, Hong-Wen
Peak bone mass (PBM) is an important determinant of osteoporosis. Circulating monocytes serve as early progenitors of osteoclasts and produce important molecules for bone metabolism. To search for genes functionally important for PBM variation, we performed a whole genome gene differential expression study of circulating monocytes in human premenopausal subjects with extremely low (N = 12) vs. high (N = 14) PBM. We used Affymetrix HG-U133 plus2.0 GeneChip (R) arrays. We identified 70 differential expression probe sets (p < 0.01) corresponding to 49 unique genes. After false discovery rate adjustment, three genes [STAT1, signal transducer and activator of transcription 1; GBPI, guanylate binding protein 1: CXCL10, Chemokine (C-X-C motif) ligand 101 expressed significantly differentially (p < 0.05). The RT-PCR results independently confirmed the significantly differential expression of GBPI gene, and the differential expression trend of STAT1. Functional analyses suggested that the three genes are associated with the osteoclastogenic processes of proliferation, migration, differentiation, migration, chemotaxis, adhesion. Therefore, we may tentatively hypothesize that the three genes may potentially contribute to differential osteoclastogenesis, which may in the end lead to differential PBM. Our results indicate that the GBPI, STAT1 and CXCL10 may be novel risk genes for the differentiation of PBM at the monocyte stage. (C) 2008 Published by Elsevier Inc.